| Literature DB >> 33801028 |
Yingzhe Xiong1, Qingwen Peng2, Chunmei Cao1, Zujie Xu1, Bing Zhang1.
Abstract
Exercise could alleviate non-alcoholic fatty liver disease (NAFLD), but it was not clear which exercise methods could effectively treat NAFLD. The purpose of this systematic review and meta-analysis was to evaluate the effects of different exercise patterns on eight indicators in patients with NAFLD. We searched PubMed, Scopus, Web of Science, China National Knowledge Infrastructure, and the Wanfang Data from its inception to 30 June 2020. This review includes all randomized controlled trials (RCT) that assessed and compared the effects of different exercise on eight indicator parameters in patients with NAFLD. The results indicate that aerobic exercises could significantly improve the eight indicators in patients with NAFLD including triglycerides (TG, weighted mean difference (WMD) = -0.53, 95%CI: -0.68~-0.39, Z = 7.37, p < 0.01), total cholesterol (TC, WMD = -0.39, 95%CI: -0.55~-0.23, Z = 4.76, p < 0.01), low density lipoprotein (LDL, WMD = -0.47, 95%CI: -0.68~-0.26, Z = 4.33, p < 0.01), high density lipoprotein (HDL, WMD = 0.12, 95%CI: 0.05~0.18, Z = 3.56, p < 0.01), alanine aminotransferase (ALT, WMD = -6.14, 95%CI: -10.99~-1.29, Z = 2.48, p < 0.05), aspartate aminotransferase (AST, WMD = -5.73, 95%CI: -9.08~-2.38, Z = 3.36, p < 0.01), and body mass index (BMI, WMD = -0.85, 95%CI: -1.19~-0.51, Z = 4.92, p < 0.01). Resistance exercises could significantly reduce the levels of TG (WMD = -0.56, 95%CI: -0.85~-0.28, Z = 3.86, p < 0.01) and AST (WMD = -2.58, 95%CI: -4.79~-0.36, Z = 2.28, p < 0.05) in the patients. High-intensity interval training could significantly improve the level of ALT (WMD = -6.20, 95%CI: -9.34~-3.06, Z = 3.87, p < 0.01) in patients with NAFLD. These three exercise methods had different effects on the eight indexes of NAFLD in our present meta-analysis, providing some reference for the establishment of exercise prescription for patients with NAFLD.Entities:
Keywords: exercises; meta-analysis; non-alcoholic fatty liver disease; randomized clinical trials
Year: 2021 PMID: 33801028 PMCID: PMC8004001 DOI: 10.3390/ijerph18063242
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram of the selected process for the included studies.
Characteristics of the included trials.
| Study | Year | Research Object | Intervention | Diet | Drug | Outcomes | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Participants | Gender (m/f) | Age | Exercise Type | Intensity | Duration (min) | Frequency (n/week) | Duration (week) | |||||
| Abdelbasset | 2020 | T1 16 | 10/6 | 54.4 ± 5.8 | HIIT | 80–85% VO2max | 40 | 3 | 8 | ①②③④⑤⑥ | ||
| T2 15 | 8/7 | 54.9 ± 4.7 | Aerobic | 60–70% VO2max | 40–50 | 3 | 8 | |||||
| C 16 | 9/7 | 55.2 ± 4.3 | No exercise | |||||||||
| Hallsworth | 2011 | T 11 | Aerobic | 60% HRM | 45–60 | 3 | 8 | ①②③⑥ | ||||
| C 8 | No exercise | |||||||||||
| Hallsworth | 2015 | T 11 | 11/0 | 54 ± 10 | HIIT | 30–40 | 3 | 12 | ①②③⑥⑦⑧ | |||
| C 12 | 12/0 | 52 ± 12 | No exercise | |||||||||
| Houghton | 2017 | T 12 | 12/0 | 54 ± 12 | Aerobic + Resistance | 45–60 | 3 | 12 | ①②③⑥⑦⑧ | |||
| C 12 | 12/0 | 51 ± 16 | No exercise | |||||||||
| Huang | 2014 | T 28 | Aerobic | 5 | 24 | Diet | ②③④⑤ | |||||
| C 28 | No exercise | |||||||||||
| Jia | 2018 | T1 154 | 78/76 | 54.6 + 7.5 | Aerobic | 50–70% HRM | 45 | 3 | 24 | ①②③④⑤⑥⑦⑧ | ||
| T2 154 | 78/76 | 55.1 ± 7.4 | Resistance | |||||||||
| C 154 | 75/79 | 54.2 + 7.5 | No exercise | |||||||||
| Liu | 2019 | T 30 | 12/18 | 60.5 ± 8.5 | Aerobic | 60 | 4 | 16 | ②③④⑤⑥ | |||
| C 30 | 17/13 | 61.5 ± 8.2 | No exercise | |||||||||
| Oh | 2014 | T 52 | 52/0 | 49.1 ± 1.3 | Aerobic | >40% HRM | 90 | 3 | 12 | Diet | ②④⑤⑥⑦⑧ | |
| C 20 | 20/0 | 53.2 ± 2.1 | No exercise | |||||||||
| Rezende | 2016 | T 19 | 19/0 | 56.2 ± 7.8 | Aerobic | 30–50 | 2 | 24 | ①②④⑤⑥⑦⑧ | |||
| C 21 | 21/0 | 54.5 ± 8.9 | No exercise | |||||||||
| Shah | 2009 | T 9 | 2/7 | 68.5 ± 1.3 | Aerobic | 90 | 3 | 24 | Diet | ②③④⑤ | ||
| C 9 | 3/6 | 68.6 ± 1.1 | No exercise | |||||||||
| Shamsoddini | 2015 | T1 10 | 10/0 | 39.7 ± 6.3 | Aerobic | 60% HRM | 45 | 3 | 8 | ①⑥⑦ | ||
| T2 10 | 10/0 | 45.9 ± 7.3 | Resistance | 45 | ||||||||
| C 10 | 10/0 | 45.8 ± 7.3 | No exercise | |||||||||
| Shojaee | 2016 | T 15 | 15/0 | 52.4 ± 2.2 | Aerobic | 40–60% HRM | 60 | 4 | 16 | ①②③④⑤⑥⑦⑧ | ||
| C 12 | 12/0 | 52.8 ± 3.0 | No exercise | |||||||||
| Sullivan | 2012 | T 12 | 4/8 | 48.6 ± 2.2 | Aerobic | 45–55% HRM | 30–60 | 5 | 16 | ①②③④⑤⑥ | ||
| C 6 | 1/5 | 47.5 ± 3.1 | No exercise | |||||||||
| Takahashi | 2015 | T 31 | 9/22 | 55.5 ± 13.2 | Resistance | 20–30 | 3 | 12 | ①②④⑤⑥⑦⑧ | |||
| C 32 | 10/12 | 51.4 ± 14.8 | No exercise | |||||||||
| Wang | 2006 | T 32 | 14/28 | 51.9 ± 7.7 | Aerobic | 60 | 3 | 12 | Drug | ①②③④⑤ | ||
| C 29 | 11/18 | 49.2 ± 8.7 | No exercise | |||||||||
| Yang | 2015 | T 48 | 41/7 | 47.1 ± 3.9 | Aerobic | 60 | 3 | 24 | ①②③④⑤ | |||
| C 48 | 42/6 | 48.4 ± 4.8 | No exercise | |||||||||
| Yao | 2006 | T 31 | Aerobic | 40 | 7 | 12 | Drug | ②③⑤⑥⑦ | ||||
| C 31 | No exercise | |||||||||||
| Zheng | 2015 | T 36 | 22/14 | 42.3 ± 10.3 | Aerobic | 60–75% HRM | 40–90 | 4 | 24 | Drug | ①②③④⑥⑦⑧ | |
| C 36 | 22/14 | 43.2 ± 9.5 | No exercise | |||||||||
Note: ① = TG; ② = TC; ③ = LDL; ④ = HDL; ⑤ = ALT; ⑥ = AST; ⑦ = GGT; ⑧ = BMI.
Figure 2The Cochrane bias risk assessment diagram for the included research.
Figure 3Subgroup analysis of different exercise styles on triglycerides (TG).
Meta regression analysis of heterogeneous factors of TG.
| Research Factors | Regression Coefficients | 95% CI | t |
|
|---|---|---|---|---|
| publication year | −0.066 | −0.128~−0.003 | −2.29 | 0.041 |
| sample size | 0.001 | −0.001~0.004 | 1.25 | 0.234 |
| intervention time | −0.009 | −0.046~0.028 | −0.55 | 0.596 |
| diet | −0.002 | −0.061~0.057 | −0.07 | 0.942 |
| medication | 0.031 | −0.043~0.104 | 0.91 | 0.380 |
Figure 4Subgroup analysis of different exercise styles on total cholesterol (TC).
Meta regression analysis of heterogeneous factors of TC.
| Research Factors | Regression Coefficients | 95%CI | t |
|
|---|---|---|---|---|
| publication year | −0.046 | −0.092~−0.001 | −2.28 | 0.045 |
| sample size | 0.002 | −0.000~0.003 | 1.83 | 0.096 |
| intervention time | −0.006 | −0.047~0.035 | −0.35 | 0.735 |
| diet | 0.037 | −0.044~0.118 | 1.02 | 0.330 |
| medication | 0.023 | −0.027~0.074 | 1.02 | 0.332 |
Figure 5Subgroup analysis of different exercise styles on low density lipoprotein (LDL).
Meta regression analysis of heterogeneous factors of LDL.
| Research Factors | Regression Coefficients | 95%CI | t |
|
|---|---|---|---|---|
| publication year | −0.047 | −0.112~−0.019 | −1.62 | 0.139 |
| sample size | 0.001 | −0.000~0.002 | 1.40 | 0.194 |
| intervention time | −0.014 | −0.039~0.011 | −1.25 | 0.244 |
| diet | 0.091 | −0.057~0.124 | 6.18 | 0.000 |
| medication | 0.021 | −0.024~0.066 | 1.06 | 0.318 |
Figure 6Subgroup analysis of different exercise styles on high density lipoprotein (HDL).
Meta regression analysis of heterogeneous factors of HDL.
| Research Factors | Regression Coefficients | 95% CI | t |
|
|---|---|---|---|---|
| publication year | 0.024 | −0.001~−0.048 | 2.20 | 0.055 |
| sample size | −0.001 | −0.002~0.000 | −2.01 | 0.076 |
| intervention time | 0.007 | −0.007~0.022 | 1.11 | 0.297 |
| diet | −0.013 | −0.033~0.006 | −1.54 | 0.159 |
| medication | 0.021 | −0.024~0.066 | −1.23 | 0.249 |
Figure 7Subgroup analysis of different exercise styles on ALT.
Meta regression analysis of heterogeneous factors of alanine aminotransferase (ALT).
| Research Factors | Regression Coefficients | 95% CI | t |
|
|---|---|---|---|---|
| publication year | 0.612 | −0.754~−1.979 | 0.99 | 0.345 |
| sample size | −0.000 | −0.043~0.043 | 0.00 | 1.000 |
| intervention time | 0.319 | −0.548~1.186 | 0.81 | 0.435 |
| diet | −1.375 | −2.172~−0.577 | −3.79 | 0.003 |
| medication | 0.962 | −0.034~1.959 | 2.13 | 0.057 |
Figure 8Subgroup analysis of different exercise styles on aspartate aminotransferase (AST).
Meta regression analysis of heterogeneous factors of AST.
| Research Factors | Regression Coefficients | 95%CI | t |
|
|---|---|---|---|---|
| publication year | −2.941 | −5.084~−0.798 | −3.36 | 0.015 |
| sample size | 0.013 | −0.014~0.040 | 1.19 | 0.278 |
| intervention time | 0.633 | −0.428~1.693 | 1.46 | 0.195 |
| diet | 0.307 | −0.141~−0.754 | 1.68 | 0.144 |
| medication | 2.574 | −1.162~3.987 | 4.46 | 0.004 |
Figure 9Subgroup analysis of different exercise styles on γ-glutamyl transpeptidase (GGT).
Figure 10Subgroup analysis of different exercise styles on body mass index (BMI).